Ensign Group [ENSG] vs HCA Healthcare [HCA] Detailed Stock Comparison
Ensign Group
NASDAQ
Loading...
HCA Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ensign Group wins in 2 metrics, HCA Healthcare wins in 18 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ensign Group | HCA Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.66 | 16.99 | HCA Healthcare |
| Price-to-Book Ratio | 4.80 | -77.25 | HCA Healthcare |
| Debt-to-Equity Ratio | 100.93 | -37.45 | HCA Healthcare |
| PEG Ratio | 1.76 | 0.68 | HCA Healthcare |
| EV/EBITDA | 23.09 | 9.96 | HCA Healthcare |
| Profit Margin (TTM) | 7.00% | 8.21% | HCA Healthcare |
| Operating Margin (TTM) | 8.46% | 15.95% | HCA Healthcare |
| EBITDA Margin (TTM) | 8.46% | 15.95% | HCA Healthcare |
| Return on Equity | 17.54% | 13,631.68% | HCA Healthcare |
| Return on Assets (TTM) | 5.30% | 11.84% | HCA Healthcare |
| Free Cash Flow (TTM) | $188.95M | $5.64B | HCA Healthcare |
| Dividend Yield | 0.20% | 0.54% | HCA Healthcare |
| 1-Year Return | 16.46% | 4.16% | Ensign Group |
| Price-to-Sales Ratio (TTM) | 2.12 | 1.30 | HCA Healthcare |
| Enterprise Value | $11.32B | $144.46B | HCA Healthcare |
| EV/Revenue Ratio | 2.45 | 1.99 | HCA Healthcare |
| Gross Profit Margin (TTM) | 16.19% | 40.97% | HCA Healthcare |
| Revenue per Share (TTM) | $81 | $292 | HCA Healthcare |
| Earnings per Share (Diluted) | $5.52 | $23.79 | HCA Healthcare |
| Beta (Stock Volatility) | 1.02 | 1.40 | Ensign Group |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ensign Group vs HCA Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ensign Group | 1.89% | 3.77% | 26.46% | 19.21% | 33.58% | 29.78% |
| HCA Healthcare | 0.18% | 2.32% | 15.39% | 7.52% | 26.72% | 36.01% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ensign Group | 16.46% | 98.37% | 194.07% | 680.98% | 3,775.06% | 4,085.44% |
| HCA Healthcare | 4.16% | 97.57% | 197.79% | 355.94% | 1,201.32% | 1,201.32% |
Performance & Financial Health Analysis: Ensign Group vs HCA Healthcare
| Metric | ENSG | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $9.77B | $94.59B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 366,450 | 1,175,558 |
| 90 Day Avg. Volume | 451,117 | 1,449,993 |
| Last Close | $172.44 | $404.97 |
| 52 Week Range | $118.73 - $173.62 | $289.98 - $417.14 |
| % from 52W High | -0.68% | -2.92% |
| All-Time High | $173.71 (Aug 22, 2025) | $417.14 (Oct 14, 2024) |
| % from All-Time High | -0.73% | -2.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | 0.06% |
| Quarterly Earnings Growth | 0.19% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.08% |
| Operating Margin (TTM) | 0.08% | 0.16% |
| Return on Equity (TTM) | 0.18% | 136.32% |
| Debt to Equity (MRQ) | 100.93 | -37.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $35.23 | $-18.61 |
| Cash per Share (MRQ) | $7.30 | $4.45 |
| Operating Cash Flow (TTM) | $462.89M | $11.93B |
| Levered Free Cash Flow (TTM) | $30.01M | $5.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.20% | 0.54% |
| Last 12-Month Dividend | $0.30 | $2.04 |
Valuation & Enterprise Metrics Analysis: Ensign Group vs HCA Healthcare
| Metric | ENSG | HCA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.66 | 16.99 |
| Forward P/E | 27.56 | 16.47 |
| PEG Ratio | 1.76 | 0.68 |
| Price to Sales (TTM) | 2.12 | 1.30 |
| Price to Book (MRQ) | 4.80 | -77.25 |
| Market Capitalization | ||
| Market Capitalization | $9.77B | $94.59B |
| Enterprise Value | $11.32B | $144.46B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.45 | 1.99 |
| Enterprise to EBITDA | 23.09 | 9.96 |
| Risk & Other Metrics | ||
| Beta | 1.02 | 1.40 |
| Book Value per Share (MRQ) | $35.23 | $-18.61 |
Financial Statements Comparison: Ensign Group vs HCA Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ENSG | HCA |
|---|---|---|
| Revenue/Sales | $1.23B | $18.61B |
| Cost of Goods Sold | $1.03B | $10.98B |
| Gross Profit | $198.79M | $7.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $103.90M | $2.97B |
| EBITDA | $140.17M | $3.85B |
| Pre-Tax Income | $112.36M | $2.42B |
| Income Tax | $27.89M | $524.00M |
| Net Income (Profit) | $84.47M | $1.89B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ENSG | HCA |
|---|---|---|
| Cash & Equivalents | $282.67M | $1.06B |
| Total Current Assets | $986.39M | $16.26B |
| Total Current Liabilities | $705.21M | $13.63B |
| Long-Term Debt | $1.91B | $42.92B |
| Total Shareholders Equity | $1.93B | $-438.00M |
| Retained Earnings | $1.50B | $-3.16B |
| Property, Plant & Equipment | $2.32B | $65.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ENSG | HCA |
|---|---|---|
| Operating Cash Flow | $97.90M | $2.65B |
| Capital Expenditures | $-42.93M | $-991.00M |
| Free Cash Flow | $29.29M | $660.00M |
| Debt Repayment | $-1.01M | $-3.90B |
| Common Stock Repurchase | $-10.79M | $-2.51B |
Short Interest & Institutional Ownership Analysis
| Metric | ENSG | HCA |
|---|---|---|
| Shares Short | 1.73M | 4.06M |
| Short Ratio | 3.98 | 2.60 |
| Short % of Float | 0.04% | 0.02% |
| Average Daily Volume (10 Day) | 366,450 | 1,175,558 |
| Average Daily Volume (90 Day) | 451,117 | 1,449,993 |
| Shares Outstanding | 57.44M | 249.98M |
| Float Shares | 55.24M | 161.52M |
| % Held by Insiders | 0.03% | 0.31% |
| % Held by Institutions | 0.95% | 0.65% |
Dividend Analysis & Yield Comparison: Ensign Group vs HCA Healthcare
| Metric | ENSG | HCA |
|---|---|---|
| Last 12-Month Dividend | $0.30 | $2.04 |
| Last 12-Month Dividend Yield | 0.20% | 0.54% |
| 3-Year Avg Annual Dividend | $0.26 | $2.29 |
| 3-Year Avg Dividend Yield | 0.05% | 0.22% |
| 3-Year Total Dividends | $0.78 | $6.88 |
| Ex-Dividend Date | Jun 30, 2025 | Mar 17, 2025 |